NKT Cells as an Ideal Anti-Tumor Immunotherapeutic

por Fujii, Shin-ichiro, Shimizu, Kanako, Okamoto, Yoshitaka, Kunii, Naoki, Nakayama, Toshinori, Motohashi, Shinichiro, Taniguchi, Masaru
Publicado 2013

Invariant NKT cells are resistant to circulating CD15(+) myeloid‐derived suppressor cells in patients with head and neck cancer

por Horinaka, Atsushi, Sakurai, Daiju, Ihara, Fumie, Makita, Yuji, Kunii, Naoki, Motohashi, Shinichiro, Nakayama, Toshinori, Okamoto, Yoshitaka
Publicado 2016

Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer

por Makita, Yuji, Kunii, Naoki, Sakurai, Daiju, Ihara, Fumie, Motohashi, Shinichiro, Suzuki, Akane, Nakayama, Toshinori, Okamoto, Yoshitaka
Publicado 2018

Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells

por Sakurai, Daiju, Uchida, Ryosuke, Ihara, Fumie, Kunii, Naoki, Nakagawa, Takuya, Chazono, Hideaki, Hanazawa, Toyoyuki, Motohashi, Shinichiro, Okamoto, Yoshitaka
Publicado 2018

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

por Kamata, Toshiko, Suzuki, Akane, Mise, Naoko, Ihara, Fumie, Takami, Mariko, Makita, Yuji, Horinaka, Atsushi, Harada, Kazuaki, Kunii, Naoki, Yoshida, Shigetoshi, Yoshino, Ichiro, Nakayama, Toshinori, Motohashi, Shinichiro
Publicado 2016